Teladoc Health Price to Free Cash Flow Ratio 2014-2025 | TDOC
Historical price to free cash flow ratio values for Teladoc Health (TDOC) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Teladoc Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-21 | 6.97 | 6.56 | |
| 2025-03-31 | 7.96 | $1.06 | 7.49 |
| 2024-12-31 | 9.09 | $0.99 | 9.14 |
| 2024-09-30 | 9.18 | $1.23 | 7.45 |
| 2024-06-30 | 9.78 | $1.18 | 8.27 |
| 2024-03-31 | 15.10 | $1.22 | 12.40 |
| 2023-12-31 | 21.55 | $1.18 | 18.31 |
| 2023-09-30 | 18.59 | $0.68 | 27.40 |
| 2023-06-30 | 25.32 | $0.39 | 64.79 |
| 2023-03-31 | 25.90 | $0.29 | 88.43 |
| 2022-12-31 | 23.65 | $0.10 | 230.96 |
| 2022-09-30 | 25.35 | $0.42 | 60.19 |
| 2022-06-30 | 33.21 | $0.68 | 48.62 |
| 2022-03-31 | 72.13 | $0.64 | 111.92 |
| 2021-12-31 | 91.82 | $0.83 | 110.80 |
| 2021-09-30 | 126.81 | $-0.97 | 0.00 |
| 2021-06-30 | 166.29 | $-1.10 | 0.00 |
| 2021-03-31 | 181.75 | $-0.96 | 0.00 |
| 2020-12-31 | 199.96 | $-0.88 | 0.00 |
| 2020-09-30 | 219.24 | $0.73 | 299.59 |
| 2020-06-30 | 190.84 | $0.62 | 306.13 |
| 2020-03-31 | 155.01 | $0.27 | 568.84 |
| 2019-12-31 | 83.72 | $0.26 | 317.12 |
| 2019-09-30 | 67.72 | $0.05 | 1390.55 |
| 2019-06-30 | 66.41 | $0.04 | 1499.10 |
| 2019-03-31 | 55.60 | $-0.01 | 0.00 |
| 2018-12-31 | 49.57 | $-0.12 | 0.00 |
| 2018-09-30 | 86.35 | $-0.29 | 0.00 |
| 2018-06-30 | 58.05 | $-0.65 | 0.00 |
| 2018-03-31 | 40.30 | $-0.71 | 0.00 |
| 2017-12-31 | 34.85 | $-0.72 | 0.00 |
| 2017-09-30 | 33.15 | $-0.84 | 0.00 |
| 2017-06-30 | 34.70 | $-0.83 | 0.00 |
| 2017-03-31 | 25.00 | $-1.10 | 0.00 |
| 2016-12-31 | 16.50 | $-1.31 | 0.00 |
| 2016-09-30 | 18.31 | $-2.63 | 0.00 |
| 2016-06-30 | 16.02 | $5.70 | 2.81 |
| 2016-03-31 | 9.60 | $-3.22 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.223B | $2.570B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| Cencora (COR) | United States | $56.472B | 19.65 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| ICON (ICLR) | Ireland | $10.225B | 9.51 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.360B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |